CONAVI MEDICAL CORP (CNVI.CA) Stock Income Statement
Canada - TSX Venture Exchange - TSX-V:CNVI - CA2059531020 - Common Stock
0.45 CAD
0 (0%)
| 2025 (2025-9-30) | 2024 (2023-12-31) | 2023 (2022-12-31) | 2022 (2021-12-31) | 2021 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.12M | 24.28M | 0.00 | 27.63M | 20.00M | |||
| Cost Of Goods | 1.50M | N/A | N/A | N/A | N/A | |||
| Gross Profit | 7.63M | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 22.48M | 11.96M | 61.65M | 70.23M | 15.80M | |||
| Research and Development | 15.27M | 442.00K | 45.45M | 52.19M | 7.94M | |||
| Selling, General, and Administrative Expenses | 6.15M | 11.26M | 15.01M | 17.09M | 7.63M | |||
| Operating Income | -14.85M | 12.32M | -61.65M | -42.61M | 4.20M | |||
| Interest Income/Expense | -11.62M | 637.50K | 6.18M | 21.42M | -29.04M | |||
| Other Income/Expense | 10.94M | 144.60K | 0.00 | 831.90K | -1.82M | |||
| Non Recurring Items | -4.99M | -3.82M | -3.19M | 0.00 | 2.47M | |||
| Income Before Taxes | -20.52M | 9.61M | -58.65M | -20.35M | -24.18M | |||
| Income Tax | N/A | 33.00K | -77.10K | 77.00K | 77.00K | |||
| Net Income | -20.52M | 9.57M | -58.58M | -20.43M | -24.18M | |||
| EBITDA | -14.04M | 12.58M | -60.46M | -41.65M | 4.44M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.36 | 0.08 | -0.53 | -0.19 | -0.36 | |||
| Statistics | ||||||||
| Gross Profit Margin | 83.61% | N/A | N/A | N/A | N/A | |||
| Profit Margin | -224.91% | 39.43% | N/A | -73.95% | -120.90% | |||
| Operating Profit Margin | -162.82% | 50.75% | N/A | -154.22% | 21.00% | |||
All data in CAD